Published on in Vol 6, No 8 (2022): August

This is a member publication of University of Oxford (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/37821, first published .
Methodological Issues in Using a Common Data Model of COVID-19 Vaccine Uptake and Important Adverse Events of Interest: Feasibility Study of Data and Connectivity COVID-19 Vaccines Pharmacovigilance in the United Kingdom

Methodological Issues in Using a Common Data Model of COVID-19 Vaccine Uptake and Important Adverse Events of Interest: Feasibility Study of Data and Connectivity COVID-19 Vaccines Pharmacovigilance in the United Kingdom

Methodological Issues in Using a Common Data Model of COVID-19 Vaccine Uptake and Important Adverse Events of Interest: Feasibility Study of Data and Connectivity COVID-19 Vaccines Pharmacovigilance in the United Kingdom

Gayathri Delanerolle   1 , MSc ;   Robert Williams   1 ;   Ana Stipancic   1, 2 , MSc ;   Rachel Byford   1 , BSc ;   Anna Forbes   1 , MBChB ;   Ruby S M Tsang   1 , PhD ;   Sneha N Anand   1 , PhD ;   Declan Bradley   3, 4 , PhD ;   Siobhán Murphy   3 , BSc ;   Ashley Akbari   5 , PhD ;   Stuart Bedston   5 , PhD ;   Ronan A Lyons   5 , MD ;   Rhiannon Owen   5 , PhD ;   Fatemeh Torabi   5 , MSc ;   Jillian Beggs   6 , PhD ;   Antony Chuter   6 , MBBS ;   Dominique Balharry   6 , PhD ;   Mark Joy   1 , PhD ;   Aziz Sheikh   6 , PhD ;   F D Richard Hobbs   1 , MBChB ;   Simon de Lusignan   1, 2 , MD

1 Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom

2 Royal College of General Practitioners, London, United Kingdom

3 Centre for Public Health, Queen’s University Belfast, Belfast, United Kingdom

4 Public Health Agency, Belfast, United Kingdom

5 Population Data Science, Swansea University, Swansea, United Kingdom

6 Usher Institute, University of Edinburgh, Edingburgh, United Kingdom

Corresponding Author: